Philip Bejon Selected Research

Malaria Vaccines

1/2022	Plasmodium falciparum-Specific Memory B-Cell and Antibody Responses Are Associated With Immunity in Children Living in an Endemic Area of Kenya.
1/2016	Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
1/2016	Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.
12/2015	Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.
1/2014	Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).
1/2014	Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection.
12/2013	Malaria vaccines: past, present and future.
7/2013	Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infection.
1/2013	Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
12/2012	A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip Bejon Research Topics

Disease

96	Malaria 10/2022 - 02/2005
42	Infections 10/2022 - 09/2005
10	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2022 - 03/2005
7	Parasitemia 06/2022 - 03/2005
5	Inflammation (Inflammations) 03/2022 - 01/2020
4	Rabies (Hydrophobia) 01/2019 - 12/2009
4	Bites and Stings (Sting) 01/2017 - 02/2005
4	Vaccinia 08/2016 - 11/2014
3	Vitamin D Deficiency 03/2022 - 01/2020
3	Iron Deficiencies 03/2022 - 01/2020
3	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2020
3	Anemia 01/2022 - 01/2019
3	Fever (Fevers) 01/2021 - 11/2007
2	Bacteremia 01/2022 - 01/2019
2	Hypersensitivity (Allergy) 10/2021 - 01/2018
2	Yellow Fever 01/2021 - 01/2019
2	Viremia 01/2019 - 04/2016
2	Hemolytic Anemia 01/2019 - 01/2018
2	Vesicular Stomatitis 01/2018 - 04/2016
2	Gastroenteritis 08/2011 - 11/2010
2	Pneumonia (Pneumonitis) 08/2011 - 11/2010
2	Asymptomatic Infections 02/2011 - 05/2009
2	Neoplasms (Cancer) 08/2006 - 04/2006
1	Pregnancy Complications 06/2022
1	Coma (Comas) 01/2022
1	Cerebral Malaria 01/2022
1	Coinfection 01/2022
1	Vomiting 10/2021
1	Headache (Headaches) 10/2021
1	Abdominal Pain (Pain, Abdominal) 10/2021
1	Poliomyelitis (Polio) 01/2021
1	Growth Disorders 01/2021
1	Microcephaly 01/2019
1	Osteomyelitis 01/2019
1	Endocarditis 01/2019
1	Glucosephosphate Dehydrogenase Deficiency 01/2018
1	Schistosomiasis (Bilharziasis) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Bacillary Dysentery (Shigellosis) 01/2017

Drug/Important Bio-Agent (IBA)

48	VaccinesIBA 06/2022 - 02/2005
29	AntigensIBA 01/2022 - 03/2005
21	AntibodiesIBA 01/2022 - 04/2008
20	Malaria VaccinesIBA 01/2022 - 02/2005
18	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2005
17	Antimalarials (Antimalarial Agents)IBA 06/2022 - 05/2005
9	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 06/2022 - 01/2013
9	ThrombospondinsIBA 08/2016 - 02/2005
8	IronIBA 03/2022 - 10/2015
7	EpitopesIBA 08/2016 - 02/2005
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 07/2005
6	RTS malaria vaccineIBA 01/2014 - 12/2008
5	Pharmaceutical PreparationsIBA 10/2021 - 11/2007
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2011
5	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2016 - 12/2008
4	Ferritins (Ferritin)IBA 03/2022 - 01/2019
4	HepcidinsIBA 01/2022 - 10/2015
4	artemisinin (artemisinine)IBA 10/2021 - 01/2019
4	Merozoite Surface Protein 1 (MSA1)IBA 01/2019 - 01/2012
4	CytokinesIBA 01/2019 - 09/2005
3	hydroxide ionIBA 03/2022 - 01/2020
3	Vitamin D FDA LinkGeneric 03/2022 - 01/2020
3	Surface Antigens (Surface Antigen)IBA 01/2022 - 01/2016
3	EnzymesIBA 01/2014 - 11/2005
2	InsecticidesIBA 10/2022 - 01/2017
2	pyrimethamine drug combination fanasil (Fansidar)FDA Link 06/2022 - 01/2015
2	Hormones (Hormone)IBA 01/2022 - 10/2015
2	Chloroquine (Aralen)FDA LinkGeneric 01/2022 - 01/2015
2	Codon (Codons)IBA 01/2022 - 01/2016
2	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 10/2021 - 01/2021
2	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 11/2006
2	Transferrin (beta 2 Transferrin)IBA 01/2020 - 01/2019
2	insulin receptor-related receptor (IRR)IBA 01/2019 - 12/2009
2	Glycoproteins (Glycoprotein)IBA 01/2018 - 04/2016
2	Immunoglobulin G (IgG)IBA 01/2018 - 01/2018
2	Peptides (Polypeptides)IBA 05/2015 - 04/2008
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2014 - 01/2012
2	ImmunosorbentsIBA 01/2014 - 01/2012
2	Interleukin-2 (IL2)IBA 01/2012 - 11/2006
2	DNA (Deoxyribonucleic Acid)IBA 11/2005 - 03/2005
1	25-hydroxyvitamin DIBA 03/2022
1	Lumefantrine FDA Link 01/2022
1	ArtesunateIBA 01/2022
1	piperaquineIBA 10/2021
1	arterolaneIBA 10/2021
1	Mefloquine (Lariam)FDA LinkGeneric 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	metal transporting protein 1 (ferroportin)IBA 01/2019
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2019
1	Histidine (L-Histidine)FDA Link 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Glutamine (L-Glutamine)FDA Link 01/2019
1	Primaquine FDA Link 01/2018

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2005
3	Contraindications 01/2022 - 01/2021
2	Intramuscular Injections 01/2022 - 01/2014
2	Chemoprevention 01/2022 - 06/2020
1	Duration of Therapy 01/2019